Zdrowie i gospodarka · 07/04/2020
Pulmonary-Allergy Drugs Advisory Committee Meeting Postponed
The FDA has postponed the Pulmonary-Allergy Drugs Advisory Committee meeting originally scheduled for April 21, 2020, due to the COVID-19 public health emergency, and will reassess future meetings on an ongoing basis.
Source: Federal Register — Food and Drug AdministrationOpen original release →